These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1373778)

  • 41. Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy.
    Elkoushy MA; Elhilali MM
    Curr Urol Rep; 2016 Jun; 17(6):44. PubMed ID: 27048160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress promotes benign prostatic hyperplasia.
    Vital P; Castro P; Ittmann M
    Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
    Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
    Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathology of BPH.
    Di Silverio F; D'Eramo G; Flammia GP; Caponera M; Frascaro E; Buscarini M; Mariani M; Sciarra A
    Minerva Urol Nefrol; 1993 Dec; 45(4):135-42. PubMed ID: 7517581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men.
    Lepor H; Shapiro E; Wang B; Liang YC
    Urology; 1996 Jan; 47(1):38-42. PubMed ID: 8560660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
    Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
    Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostatic enlargement, symptomatology and pressure/flow evaluation: interrelations in patients with symptomatic BPH.
    Poulsen AL; Schou J; Puggaard L; Torp-Pedersen S; Nordling J
    Scand J Urol Nephrol Suppl; 1994; 157():67-73. PubMed ID: 7524143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
    Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
    Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlations between parameters in pressure-flow analysis and histological compositions in prostate in patients with benign prostatic hyperplasia.
    Ichiyanagi O; Nakada T
    Urol Int; 1997; 59(3):154-60. PubMed ID: 9428431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative topographic distribution of epithelial and mesenchymal components in benign prostatic hypertrophy.
    Costa P; Robert M; Sarrazin B; Mottet N; Navratil H
    Eur Urol; 1993; 24(1):120-3. PubMed ID: 7689969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 1, Pathological Background and Clinical Implications.
    Sun F; Crisóstomo V; Báez-Díaz C; Sánchez FM
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):1-7. PubMed ID: 26581418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Quantitative morphometry of hyperplastic hypoechoic nodules in the prostatic outer gland].
    Li X; Wang N; Shi HY; Zhang Y; Fu XS; Li JL; Xu JH; Tang J
    Zhonghua Nan Ke Xue; 2005 Feb; 11(2):91-3. PubMed ID: 15755023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of percent area density of epithelial and stromal components in development of prostatic hyperplasia in spontaneously hypertensive rats.
    Yamashita M; Zhang X; Shiraishi T; Uetsuki H; Kakehi Y
    Urology; 2003 Feb; 61(2):484-9. PubMed ID: 12597986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.